27 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(nn) Cybersecurity
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
regarding the Company or its Subsidiaries or their financial results or prospects.
(nn) Cybersecurity. (i)(x) There has been no security breach
8-K
EX-10.1
2ugo4isc
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
424B5
4e9hxpcselx2b2cacrx
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
683iq2bi0wf9735pqvn
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
3s7h exkj1wwdtza
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
rh72574 4vwfd7jji6o
7 Apr 22
Prospectus supplement
4:46pm
S-3
op015jueied8fv g4e4a
4 Feb 22
Shelf registration
4:36pm
10-K
9jmte 0rl
24 Sep 21
Annual report
7:31am
424B3
gizjh v1b
22 Jul 21
Prospectus supplement
10:27am
424B3
csews4ew
16 Mar 21
Prospectus supplement
12:00am
10-Q
1sjvv ab0dzg
17 Dec 20
Quarterly report
12:00am
424B4
8zogb5vhhfl5mj
13 Nov 20
Prospectus supplement with pricing info
8:52pm